Adagio Files FDA Submission For Ventricular Ablation System
Adagio Medical’s FDA submission for its ultra-low temperature ventricular ablation system could expand treatment options for drug-refractory ventricular tachycardia, offering deeper lesion creation, fewer ICD shocks, reduced antiarrhythmic dependence, and improved procedural outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.